Found: 5
Select item for more details and to access through your institution.
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 702, doi. 10.1093/cid/ciad656
- By:
- Publication type:
- Article
Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 10, p. 1767, doi. 10.1093/cid/ciab725
- By:
- Publication type:
- Article
The use of Neurobion® Forte in the Treatment of Pellagra in an adult on anti-TB treatment: A case report from Lusaka, Zambia.
- Published in:
- Medical Journal of Zambia, 2021, v. 48, n. 1, p. 58, doi. 10.55320/mjz.48.1.757
- By:
- Publication type:
- Article
Engagement of private health care facilities in TB management in Lusaka district of Zambia: lessons learned and achievements.
- Published in:
- BMC Public Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12889-024-18285-4
- By:
- Publication type:
- Article
ADEQUATE DTG EXPOSURE IN INFANTS ON RIFAMPICIN TREATMENT RECEIVING TWICE-DAILY DTG.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 332
- By:
- Publication type:
- Article